Showing posts with label microbicides. Show all posts
Showing posts with label microbicides. Show all posts

Monday, July 18, 2011

Antiretroviral prevention methods 'not in competition' with each other

via AIDS map, By Keith Alcorn

Antiretroviral prevention methods are not in competition, and policy makers and providers need to start to thinking about how antiretrovirals,pre-exposure prophylaxis and microbicides will be provided as part of a combination prevention package – and who will benefit most from each method, delegates heard at a satellite meeting on the opening day of the Sixth International AIDS Society Conference in Rome.

“You don’t want to have the family planning clinic here, the pills clinic here, the injections clinic here, and the microbicides clinic over here,“ said Dr Stephen Becker of the Bill and Melinda Gates Foundation.

Delegates were discussing the rapidly changing landscape of HIV prevention methods that use antiretroviral drugs.

“It’s very important not to pit prevention technologies against each other,” said Renée Ridzon of the Bill and Melinda Gates Foundation.

Read more.

Friday, May 21, 2010

International Microbicides Conference Gets Underway in Pittsburgh


Article from the Pittsburgh Tribune-Review covering the Microbicides 2010 conference:

Despite advances in the treatment of HIV, experts warn that the global fight against the disease has a long way to go.

"For every person you put on treatment in the developing world, another two or three people get infected," said Dr. Ian McGowan, a leading investigator at Microbicide Trials Network, based at Magee-Womens Research Institute and the University of Pittsburgh in Oakland. "The figures are still depressing."

More than 33 million people are living with HIV, and doctors diagnose about 2.5 million cases a year globally, according to UNAIDS, the United Nations' AIDS-fighting agency.

Over the next four days, the Microbicide Trials Network, or MTN, will host an international gathering of HIV experts aimed at discussing ways to prevent the disease. The International Microbicides Conference, to be held at the David L. Lawrence Convention Center, Downtown, is co-chaired by McGowan and Sharon Hillier, the network's principal investigator and a world-known microbiologist.

Read the rest...

Friday, March 27, 2009

Microbicide advocates stress options - Chicago Free Press


via Chicago Free Press, by Amy Wooten

With over 33 million people living with HIV/AIDS across the globe, advocates stress that more prevention options are needed, and a product currently in development—microbicides—could potentially save millions of people from infection.

Microbicides have for years been in development to reduce HIV transmission, and some even aim to prevent other STDs, as well. But since the rectum and vagina are biologically very different, safe and effective microbicides for both areas need to be developed.

The rectum is what AIDS Foundation of Chicago (AFC) Director of Advocacy and International Rectal Microbicides Advocates (IRMA) chair Jim Pickett describes as “the perfect storm” for HIV infection. Although women will primarily use vaginal microbicides, safety trials are being conducted to determine if they are safe for anal use. Both men and women will ideally utilize rectal microbicides.

According to AFC policy manager Jessica Terlikowski, Chicago has been a hub for microbicide activism.

“This is the city where microbicide advocacy has been taking place for the last 10 years,” Terlikowski said.

That is why advocates are ecstatic that an upcoming clinical trial of a vaginal microbicide gel will take place in Chicago, as well as other cities. Terlikowski said that the trial would most likely be launched this summer and added that support for microbicide research and development is on the rise.

Read the rest.


Monday, August 25, 2008

WE ALL FORGOT THE CONDOM

You may have heard that HIV infection is on the rise, or that the effort to develop a vaccine has dead-ended.

But in recent years, with every new setback and breakthrough—including sensational word of a new “morning after” pill—gay men have been changing their behavior, adopting ingenious methods to keep the virus at bay. As a result, the one commandment of the past twenty-five years—always wear a condom—is fast becoming a relic.

Read the rest in GQ.

[note from LifeLube - it is too damn bad that the author virtually ignored the research, development and advocacy around the creation of safe, effective and acceptable rectal microbicides. Currently in development, a microbicide is a cream or gel, or maybe a douche or an enema, that could be used to reduce a person’s risk of HIV infection vaginally or rectally. Rectal microbicides could offer both primary protection in the absence of condoms and back-up protection if a condom breaks or slips off during anal intercourse. For those unable or unwilling to use condoms, rectal microbicides could be a safe and effective alternative means of reducing risk, especially if they were unobtrusive and/or enhanced sexual pleasure enough to motivate consistent use. Such alternatives are essential if we are to address the full spectrum of prevalent sexual practices and the basic human need for accessible, user-controlled HIV and STD prevention tools. Click here for the site of the International Rectal Microbicide Advocates (IRMA) and learn more.]

Wednesday, June 18, 2008

The Future of Sex from New Delhi to Chicago - NEXT WEEK

Direct from Delhi - Microbicides 2008 Comes to Sweet Home Chicago


RSVP - it's FREE.

NEXT WEEK
Wednesday June 25, 2008
6:00-8:00 p.m.

University Center
525 S. State Street
Chicago

Please join the Chicago Women and Girls HIV Prevention Coalition and the International Rectal Microbicide Advocates for this exclusive update from across the globe on the current developments in microbicide research and advocacy - direct from the Microbicides 2008 conference held in New Delhi, India.

Microbicides are products currently in development that a person could use to reduce her or his risk from infection of HIV and other STDs.

RSVP - it's FREE.

This dynamic event will feature microbicide advocacy leaders:

Latifa Boyce
Alliance for Microbicide Development

Dázon Dixon Diallo
SisterLove, Inc.

Jim Pickett
International Rectal Microbicide Advocates
AIDS Foundation of Chicago


Tuesday, May 20, 2008

Direct from Delhi - Microbicides 2008 Comes to Sweet Home Chicago

Direct from Delhi - Microbicides 2008 Comes to Sweet Home Chicago

Wednesday June 25, 2008

6:00-8:00 p.m.

University Center

525 S. State Street

Chicago, IL

Please join the Chicago Women and Girls HIV Prevention Coalition and the International Rectal Microbicide Advocates for this exclusive update from across the globe on the current developments in microbicide research and advocacy - direct from the Microbicides 2008 conference held in New Delhi, India. Microbicides are products currently in development that a person could use to reduce her or his risk from infection of HIV and other STDs.

RSVP - it's FREE.

This dynamic event will feature microbicide advocacy leaders:

Latifa Boyce
Alliance for Microbicide Development

Dázon Dixon Diallo
SisterLove, Inc.

Jim Pickett
International Rectal Microbicide Advocates
AIDS Foundation of Chicago


Saturday, January 12, 2008

Is FDA putting gay men at risk?


[via Bay Windows]
Thursday Jan 10, 2008
"...the small amount of N-9 they (condoms) contain is dangerous if used rectally and offers no documented contraceptive benefit."

The Food and Drug Administration (FDA) announced in December that it is adopting a new rule that would require warning labels on contraceptive products that contain the spermicide nonoxynol-9 (N-9) but the federal agency is delaying the establishment of a similar rule on condoms containing N-9.

The Deputy Director for the Global Campaign for Microbicides, Anna Forbes, said it appeared to her that the FDA was "stalling" on the implementation of the N-9 rules.

Microbicides refer to a wide range of topically applied products including gels, creams and suppositories that prevent the transmission of AIDS and other STDs. The Global Campaign is a nonprofit organization that works with a network of over 285 non-governmental organizations to help accelerate the development of microbicides. It has called for the removal of N-9 from all condoms.

The FDA is considering labeling requirements for N-9 condoms separately from other N-9 contraceptive products because it classifies condoms as "medical devices." The two major manufacturers of N-9 condoms, Church and Dwight, the makers of the Trojan brand, and Ansell, the maker of the LifeStyles brand, wrote to the FDA suggesting that warning consumers about N-9 condoms could be confusing and could stop some consumers from using condoms at all. That objection was the major factor in causing the FDA to delay N-9 labeling rules.

Citing that reason, the FDA opted to study the issue further. The first phase of the planned N-9 condom study will be completed by February 2008 and the second phase, which will take about 17 weeks, will begin after the FDA analyzes the first study, according to FDA spokeswoman Peper Long.

A number of AIDS organizations have joined with the Global Campaign in calling for the removal of N-9 from condoms.

In an advisory letter to the FDA last year, Fred Dillon, who was then the San Francisco AIDS Foundation’s Public Policy and Communications Director, wrote: "[T]he San Francisco AIDS Foundation has joined with a broad coalition of women’s health groups, HIV/AIDS organizations, state and local public health officials, and research scientists calling on manufacturers to remove N-9 from condoms and lubricants, because the small amount of N-9 they contain is dangerous if used rectally and offers no documented contraceptive benefit. While there has been progress on this front, we are disappointed that some companies continue to produce N-9 condoms. The San Francisco AIDS Foundation strongly encourages the FDA to take immediate steps to end the manufacturing or sale."

Read the rest.

Read another LifeLube post on this topic.

Learn more about the development of safe and effective rectal microbicides.



Saturday, December 15, 2007

AIDS researchers find protein in semen that greatly boosts HIV infection

[image by Matthias Herrmann]


Sabin Russell, Chronicle Medical Writer

Published 12/14/07



German AIDS researchers have discovered a protein common in semen that boosts the infectious potential of HIV 100,000-fold - a remarkable finding that may show how the virus can spread through sexual contact and also suggests new strategies to stop the epidemic.

If scientists can find a drug or chemical that blocks these infection-promoting proteins, it would go a long way toward development of a microbicide, a vaginal cream or gel that could protect sex partners against AIDS.

What is catching scientists' attention is the 100,000-fold increase. "I was so surprised that I did not believe the numbers," said Dr. Frank Kirchhoff, leader of the University of Ulm laboratory that found the protein. "But we did the experiment multiple times, and the results were always the same."

The discovery was made possible by advanced techniques in laboratory screening for tiny proteins. There are more than 900 different kinds in human semen, and these proteins in turn break down into smaller molecular chains that also may carry out important biological tasks.
In this case, researchers at the University of Ulm were screening hundreds of different molecules from semen samples in the hope of finding some that naturally blocked HIV, the virus that causes AIDS.

Instead, they stumbled upon protein fragments that do the opposite. The fragments dramatically boost HIV infection by clustering into microscopic rafts that ferry crowds of virus particles to cell surfaces, like landing craft disgorging invaders on a beach.

Their findings were released today in advance of Friday's publication of the journal Cell.

Although HIV has been understood to be a sexually transmitted disease for a quarter century, relatively little work has been done in analyzing what role semen may play in its transmission. And, it seems, few scientists have spent much time analyzing what Kirchhoff calls "pools" of donated semen. "People haven't dissected the individual components of semen," he said.
The latest work is the product of an emerging field in biotechnology called proteomics, the study of the molecular structure and function of proteins.

The new study suggests that scientists may have been missing something very important. "This is one of the most interesting new perspectives on HIV transmission to emerge in years," said Dr. Warner Greene, director of the Gladstone Institute of Virology and Immunology in San Francisco.

Greene said the work may solve a mystery that has puzzled AIDS researchers - why a virus that appears weakly infectious in laboratory dishes can spread explosively through sexual contact.

When researchers try to infect human cells under a microscope with HIV, it takes between 1,000 and 100,000 particles of the virus to cause a successful infection. That's weak, as viral infectivity goes. But when the proteins found by Kirchhoff are added to the mix, it is possible to start a successful infection with as few as three particles of virus.

If such a weak virus can be turned into a monster by a molecule present in semen, it raises the possibility that knocking that molecule out - or even hobbling it - could make HIV suddenly much more difficult to spread.

Greene is so enthusiastic about this discovery that he has started a project to find ways of blocking the protein. But he concedes that this search will not be quick or easy.

Dr. Tony Fauci, director of the National Institute for Allergy and Infectious Diseases, said the science behind the German study is impressive, but the laboratory dish findings are a long way from producing a practical solution for people. "It is a surprising finding, but I would be cautious about how important this is going to be," he said.

Fauci also noted that sexual transmission is only one route of HIV infection. Women can pass the virus to their newborns with breast milk, where presumably no similar HIV-promoting proteins exist. It is also clear that other factors, such as genital ulcers caused by diseases including herpes and syphilis, have a well-documented role in enhancing transmission of the virus.

Read the rest in the San Francisco Chronicle.

Wednesday, November 14, 2007

A pivotal moment in HIV prevention

GLENDA GRAY AND MITCHELL WARREN
GUEST COLUMNISTS via seattlepi.com


Last week's announcement about the failure of the leading AIDS vaccine candidate developed by Merck & Co. is another in a series of disappointing setbacks in HIV prevention. How we as a global community choose to respond to this news, however, is the real test.

Historically, it has taken decades -- and more setbacks than advances -- from the discovery of a virus or bacteria until an effective vaccine is licensed. Typhoid was discovered in 1884, but there was no vaccine until 1989. Malaria, discovered in 1893, still has no vaccine. The measles vaccine took 42 years to develop.

In the 1930s, two experimental polio vaccines failed because they were determined to be unsafe, and polio vaccines were almost abandoned. At the time, we understood how to prevent infection by sanitation and avoiding public swimming areas, just as we know how to stop HIV infection today. We needed new tools then, and we need them now.

Today's question of how we deal with these setbacks will loom large in any reckoning of our response to the most severe epidemic of our time.

There are more than 4 million new infections every year. In South Africa, where three of this year's prevention trials have taken place, there are communities where nearly one-third of women between 25 and 29 are infected with HIV. For every one individual who starts on life-saving antiretroviral medications, there are six others who are newly diagnosed.

These are mind-numbing, tragic figures. They remind us that there is only one viable answer to the question -- "What do we do now?" -- that has been posed by many observers inside and outside of the HIV prevention field in recent weeks.

We do more of everything.

There is a drastic shortfall in funds for implementing proven prevention strategies, including male and female condoms, clean needles, prevention of mother-to-child transmission and risk-reduction counseling. In December 2006, we learned that male circumcision showed strong protective benefits for HIV-negative men. This strategy must also be made available in communities where it can have an impact.

We must do more to bring comprehensive care, treatment and support to people already living with HIV worldwide. Global targets have been set and missed and are in danger of being missed again.

And while we do those things, we must continue to search for additional prevention strategies, including vaccines, microbicides, oral prevention or pre-exposure prophylaxis and herpes treatment.

To pit proven prevention and treatment against research is a false and dangerous dichotomy. The range of tools that we have today is not reaching every person at risk. And even if it did, it is not enough. Women and men, adolescents, boys and girls and infants need more choices when it comes to HIV prevention.

The best approach to prevention is one that provides the most options. There will be no magic bullet, be it a condom or a clean needle today or a vaccine tomorrow. There is only the ethical and moral imperative to develop a multi-faceted response that is a match for the multiple drivers of the epidemic.

In the wake of the failure of the Merck vaccine, the AIDS vaccine field will need to make carefully considered decisions about whether to move forward with planned trials of other vaccine candidates, but the field will keep moving forward. It must, as the history of other epidemic diseases tells us that an essential tool to stopping epidemics is an effective vaccine.

As disappointing as recent failures are, donors and advocates, scientists and physicians, volunteers and their families must all guard against "failure fatigue." We must respond loudly and clearly to suggestions that enough money has been spent; that it would be easier and wiser to move on rather than to press on.

To do so would be to ignore the reality of the epidemic today, and to overlook the lessons from history about the long, slow process of vaccine discovery. We cannot afford to walk away from science, or from the generations to come. Rather than giving up hope, we must redouble our efforts in prevention research and stand firm in our commitment to scientific inquiry. Millions of lives -- today and tomorrow -- depend on it.

Glenda Gray is the co-director of the Perinatal HIV Research Unit in South Africa. Mitchell Warren is the executive director of the AIDS Vaccine Advocacy Coalition in New York.

Saturday, August 11, 2007

HIV Microbicides: A Science and Public Policy Update


The San Francisco AIDS Foundation's series of podcasts just did a nice, short piece on microbicides.


In this episode, they share some of the latest information about research on microbicides — chemical compounds now in development — that may help prevent HIV transmission. Courtney Mulhern-Pearson, a policy analyst in the San Francisco AIDS Foundation's Department of Science and Public Policy explains that although there are no HIV microbicides approved for use in humans, research may soon yield another effective tool for HIV prevention.


Click here to listen.


To learn more about rectal microbicides and how you can get involved in advocacy activities, click here.
Related Posts Plugin for WordPress, Blogger...

select key words

2007 National HIV Prevention Conference 2009 National LGBTI Health Summit 2011 LGBTI Health Summit 2012 Gay Men's Health Summit 2012 International AIDS Conference ACT Up AIDS AIDS Foundation of Chicago Africa BUTT Bisexual Bisexual Health Summit Brian Mustanski Center on Halsted Charles Stephens Chicago Chicago Black Gay Men's Caucus Chicago Task Force on LGBT Substance Use and Abuse Chris Bartlett Coaching with Jake Congress David Halperin David Munar Dr. James Holsinger Dr. Jesus Ramirez-Valles Dr. Rafael Diaz Dr. Ron Stall ENDA Ed Negron Eric Rofes FTM Feast of Fun Feel the love... Friday is for Faeries Gay Men's Health Summit 2010 HCV HIV HIV care HIV drugs HIV negative HIV positive HIV prevention HIV stigma HIV strategic plan HIV testing HIV/AIDS HPV Howard Brown Health Center IML IRMA Illinois International AIDS Conference Jim Pickett LGBT LGBT adoption LGBT culture LGBT health LGBT rights LGBT seniors LGBT youth LGBTI community LGBTI culture LGBTI health LGBTI rights LGBTI spirituality LGV Leon Liberman LifeLube LifeLube forum LifeLube poll LifeLube subscription Lorenzo Herrera y Lozano Lymphogranuloma Venereum MRSA MSM Monday Morning Perk-Up National AIDS Strategy National Gay Men's Health Summit One Fey's Tale Peter Pointers Pistol Pete PnP PrEP President Barack Obama Presidential Campaign Project CRYSP Radical Faerie STD Senator Barack Obama Sister Glo Sisters of Perpetual Indulgence Susan Kingston Swiss declaration Ted Kerr Test Positive Aware Network The "Work-In" The 2009 Gay Men's Health Agenda Tony Valenzuela Trans Gynecology Access Program Trans and Intersex Association Trevor Hoppe Who's That Queer Woof Wednesday You Tube abstinence only activism advocacy african-american aging issues anal cancer anal carcinoma anal health anal sex andrew's anus athlete ball scene bareback porn barebacking bathhouses bears big bold and beautiful bisexuality black gay men black msm blood ban blood donor body image bottom chubby chaser circumcision civil rights civil union communication community organizing condoms crystal meth dating dating and mating with alan irgang depression disclosure discrimination domestic violence don't ask don't tell douche downlow drag queen emotional health exercise female condom fitness gay culture gay identity gay latino gay male sex gay marriage gay men gay men of color gay men's health gay pride gay rights gay rugby gay sex gay youth gender harm reduction hate crime health care health care reform health insurance hepatitis C hiv vaccine homophobia homosexuality hottie hotties how are you healthy? human rights humor hunk immigration international mr. leather internet intimacy leather community leathersex lifelube survey love lube lubricant masturbation mental health microbicides middle music negotiated safety nutrition oral sex physical health pleasure podcast policy politics poppers porn post-exposure prophylaxis prevention prostate prostate cancer public health public sex venues queer identity racism recovery rectal microbicides relationships religion research safe sex semen sero-adaptation sero-sorting seroguessing sex sexual abuse sexual addiction sexual health sexual orientation smoking social marketing spirituality stigma stonewall riots substance abuse treatment substance use suicide super-bug superinfection syphilis testicle self-examination testicular cancer testing top trans group blog transgender transgender day of remembrance transgendered transmen transphobia transsexual universal health care unsafe sex vaccines video violence viral load writers yoga youtube